AKOVA, M. And ÜNAL, S. 2021. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. TRIALS , vol.22, no.1 .

AKOVA, M., & ÜNAL, S., (2021). A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. TRIALS , vol.22, no.1.

AKOVA, MURAT, And SERHAT ÜNAL. "A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial," TRIALS , vol.22, no.1, 2021

AKOVA, MURAT And ÜNAL, SERHAT. "A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial." TRIALS , vol.22, no.1, 2021

AKOVA, M. And ÜNAL, S. (2021) . "A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial." TRIALS , vol.22, no.1.

@article{article, author={MURAT AKOVA And author={SERHAT ÜNAL}, title={A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial}, journal={TRIALS}, year=2021}